EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Myelodysplastic Syndrome (MDS) With KMT2A::CBL Rapidly Progressed to Acute Myeloid Leukaemia (AML)

Ke Xu, Temenuzhka Boneva, Elisabeth Nacheva

eJHaem · 2026-04 · 7 (2)

DOI: 10.1002/jha2.70260 ↗

Kurz gefasst

Fachartikel in der Zeitschrift eJHaem, online erschienen am 09.03.2026. Verfasst von Ke Xu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Haematology University College London Hospitals NHS Foundation Trust London UK. Die Arbeit nennt 3 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Haematology University College London Hospitals NHS Foundation Trust London UK.
  • Specialist Integrated Haematology Malignancy Diagnostic Service Health Services Laboratories University College London Hospitals NHS Foundation Trust London UK.
  • UCL School of Life and Medical Sciences University College London London UK.

Zitieren

APA

Xu, K., Boneva, T., & Nacheva, E. (2026). Myelodysplastic Syndrome (MDS) With KMT2A::CBL Rapidly Progressed to Acute Myeloid Leukaemia (AML). eJHaem, 7(2). https://doi.org/10.1002/jha2.70260

Vancouver

Xu K, Boneva T, Nacheva E. Myelodysplastic Syndrome (MDS) With KMT2A::CBL Rapidly Progressed to Acute Myeloid Leukaemia (AML). eJHaem. 2026;7(2). doi:10.1002/jha2.70260

BibTeX
@article{Xu2026,
  author = {Xu, Ke and Boneva, Temenuzhka and Nacheva, Elisabeth},
  title = {Myelodysplastic Syndrome (MDS) With KMT2A::CBL Rapidly Progressed to Acute Myeloid Leukaemia (AML)},
  journal = {eJHaem},
  year = {2026},
  volume = {7},
  number = {2},
  doi = {10.1002/jha2.70260}
}
Kostenlos starten →